Artefact equips companies to better exploit their data

Artefact equips companies to better exploit their data
Artefact
      equips
      companies
      to
      better
      exploit
      their
      data

Vincent Luciani, a graduate of HEC and Polytechnique, co-founded in 2015, with Guillaume de Roquemaurel and Philippe Rolet, the consulting firm in data analysis Artefact. He is aiming for two to three acquisitions. He is the guest of the Club Entrepreneurs Challenges – Montefiore Investment.

Challenges – Why did you create a data analysis consulting company?

Vincent Luciani – After Polytechnique, I started my career at McKinsey, in consulting, on a wide variety of subjects before specializing. I felt that many companies lacked a technological component to exploit their data. With Guillaume de Roquemaurel and Philippe Rolet, we understood that we could build tech solutions by offering them to companies in order to solve their problems.

Concretely, what projects are you working on?

We provide a team that works with a customer on a given subject. At Orange, for example, around a hundred people worked on their infrastructures and on personalized recommendation programs for their customers. We developed an application with their teams so that they do not encounter any difficulties during fiber optic deployments. We used generative AI, in particular to improve the detection of failures on their networks.

What is your business model?

We are not a SaaS platform, we do not sell software. Our goal is to transfer skills to our customers. We give them the algorithms and the rights to use them. They improve on technical subjects, we do not want to create dependency on us.

How was Artefact’s growth organized?

There were several phases. In 2017, we met the advertising agency Netbooster, which does digital marketing, but has not taken the data turn. We merged with it and found ourselves listed on the stock exchange. Until 2021, the situation was quite chaotic. That year, we left the stock exchange with 80 million euros in turnover. We were then profitable and employed around 750 people worldwide. The Ardian and Cathay Capital funds, which bought the shares, allowed us to[…]

- challenges.fr

Also read

-

PREV Medincell Partner Teva Provides Update on Pivotal Phase 3 Clinical Trial of Olanzapine Long-Acting Injection (LAI)
NEXT France and Germany in “reverse situation”, according to a study